NCT06635694Active, not recruiting
naVIGation Invitations Liver surveillANce upTake
Source: ClinicalTrials.gov · Last updated 14 Jan 2026
Brief summary (registry, in English)
This study aims to evaluate the efficacy of Patient Navigators and mailed surveillance invitations on attendance of Hepatocellular Carcinoma (HCC) ultrasound surveillance appointments. The investigators hypothesise that mailed invitations and Patient Navigators will improve attendance at HCC surveillance appointments and increase the proportion of patients diagnosed at an early stage, compared with a control group receiving usual care.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 652 (actual)
- First submitted
- 8 Oct 2024
- Start date
- 27 Feb 2025
- Primary completion date
- 19 Aug 2027
- Lead sponsor
- Imperial College London
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06635694
What you commit to
- Study type: Observational
- Participants enrolled: 652
- From 27 Feb 2025 to the primary completion date, 19 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous or current diagnosis of HCC
- Previous liver transplant
Other
- Child Pugh C cirrhosis
- Frailty (Clinical Frailty Scale \>7)
Who the study is looking for
- 18 years of age or older
- ECOG performance status of 0-2
- Eligible for HCC surveillance as defined by NICE and EASL criteria
- Child Pugh A or B cirrhosis
- Child Pugh C cirrhosis AND on liver transplant waiting list
- High risk chronic hepatitis B
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Imperial College Healthcare NHS Trust Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.